{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:47:35Z","timestamp":1789958855108,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,27]],"date-time":"2020-12-27T00:00:00Z","timestamp":1609027200000},"content-version":"vor","delay-in-days":361,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1136\/esmoopen-2020-000746","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T11:40:16Z","timestamp":1598269216000},"page":"e000746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"S4","title":["How I treat adverse effects of CAR-T cell therapy"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9925-3048","authenticated-orcid":false,"given":"Lucrecia","family":"Y\u00e1\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"S\u00e1nchez-Escamilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel-Angel","family":"Perales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/esmoopen-2020-000746_bb0010","author":"Frey"},{"key":"10.1136\/esmoopen-2020-000746_bb0015","author":"Maude"},{"key":"10.1136\/esmoopen-2020-000746_bb0020","author":"Neelapu"},{"key":"10.1136\/esmoopen-2020-000746_bb0025","author":"Schuster"},{"key":"10.1136\/esmoopen-2020-000746_bb0030","author":"Pennisi"},{"key":"10.1136\/esmoopen-2020-000746_bb0035","author":"Lee"},{"key":"10.1136\/esmoopen-2020-000746_bb0040","author":"Yakoub-Agha"},{"key":"10.1136\/esmoopen-2020-000746_bb0045","author":"Santomasso"},{"key":"10.1136\/esmoopen-2020-000746_bb0050","author":"Brudno"},{"key":"10.1136\/esmoopen-2020-000746_bb0055","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.7558","article-title":"Preliminary results of earlier steroid use with axicabtagene ciloleucel (axi-cel) in patients with relapsed\/refractory large B-cell lymphoma (R\/R LBCL)","volume":"37","author":"Topp","year":"2019","journal-title":"JCO"},{"key":"10.1136\/esmoopen-2020-000746_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-020-0280-y","article-title":"Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia","volume":"10","author":"Liu","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1136\/esmoopen-2020-000746_bb0065","author":"Jain"},{"key":"10.1136\/esmoopen-2020-000746_bb0070","author":"Hill"},{"key":"10.1136\/esmoopen-2020-000746_bb0075","author":"Cordeiro"},{"key":"10.1136\/esmoopen-2020-000746_bb0080","author":"Locke"},{"key":"10.1136\/esmoopen-2020-000746_bb0085","author":"Hill"},{"key":"10.1136\/esmoopen-2020-000746_bb0090","author":"Fried"},{"key":"10.1136\/esmoopen-2020-000746_bb0095","author":"Hill"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702920301150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702920301150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/esmoopen-2020-000746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:22:36Z","timestamp":1761855756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702920301150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":18,"alternative-id":["S2059702920301150"],"URL":"https:\/\/doi.org\/10.1136\/esmoopen-2020-000746","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How I treat adverse effects of CAR-T cell therapy","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/esmoopen-2020-000746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology; Originally published by BMJ.","name":"copyright","label":"Copyright"}],"article-number":"e000746"}}